Results
The guarantee, in practice.
Each result below came from a qualifying study under our contractual enrollment commitment. No impressions billed. No clicks billed. Randomized patients only.
60+
patients randomized
Published Results
Across all campaigns to date. The six engagements below are our most thoroughly documented: full spend, cost per patient, and outcome reported for each.
The average per-patient fee for a Phase II-III study ranges from $3,000 to $15,000 depending on indication. For most sites, a single randomized patient returns the cost of the campaign.
Your study could be next.
Find out if it qualifies for our contractual enrollment commitment. Free feasibility evaluation. No call required.
Check if your study qualifiesAll campaigns developed for IRB review and deployed in accordance with FDA guidance on clinical trial advertising.